Gene · 2317
Papers3,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment. | Front Endocrinol (Lausanne) | 2023 | 38116315 | PubTator, text mining | PubMed |
| Comprehensive review on gene mutations contributing to dilated cardiomyopathy. | Front Cardiovasc Med | 2023 | 38107262 | PubTator, text mining | PubMed |
| A cross-sectional analysis of syncytiotrophoblast membrane extracellular vesicles-derived transcriptomic biomarkers in early-onset preeclampsia. | Front Cardiovasc Med | 2023 | 38099221 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. | Sci Rep | 2023 | 38097783 | PubTator, text mining | PubMed |
| Blood-based DNA methylation in advanced Nasopharyngeal Carcinoma exhibited distinct CpG methylation signature. | Sci Rep | 2023 | 38086861 | PubTator, text mining | PubMed |
| Genetic Studies of Actinic Keratosis Development: Where Are We Now? | Ann Dermatol | 2023 | 38086352 | PubTator, text mining | PubMed |
| An Important Role in Novel Immune Mechanism and Diagnostic Model of Ankylosing Spondylitis: The CeRNA-ADRB2 Network. | J Inflamm Res | 2023 | 38084105 | PubTator, text mining | PubMed |
| Dissecting the basis for differential substrate specificity of ADAR1 and ADAR2. | Nat Commun | 2023 | 38081817 | PubTator, text mining | PubMed |
| Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer. | iScience | 2023 | 38077153 | PubTator, text mining | PubMed |
| Genome tuning through HLA and KIR gene clusters impact susceptibility to dengue. | Infect Med (Beijing) | 2023 | 38073888 | PubTator, text mining | PubMed |
| Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. | Cancers (Basel) | 2023 | 38067373 | PubTator, text mining | PubMed |
| A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study. | PLoS One | 2023 | 38051749 | PubTator, text mining | PubMed |
| MESPool: Molecular Edge Shrinkage Pooling for hierarchical molecular representation learning and property prediction. | Brief Bioinform | 2023 | 38048081 | PubTator, text mining | PubMed |
| Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges. | Biomark Res | 2023 | 38037114 | PubTator, text mining | PubMed |
| TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells. | PLoS One | 2023 | 38033034 | PubTator, text mining | PubMed |
| Shedding Light on the Role of ERAP1 in Axial Spondyloarthritis. | Cureus | 2023 | 38024089 | PubTator, text mining | PubMed |
| Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8+ T cells. | Front Immunol | 2023 | 38022506 | PubTator, text mining | PubMed |
| Bidirectional interplay between metabolism and epigenetics in hematopoietic stem cells and leukemia. | EMBO J | 2023 | 38010205 | PubTator, text mining | PubMed |
| Intestinal Paneth cell differentiation relies on asymmetric regulation of Wnt signaling by Daam1/2. | Sci Adv | 2023 | 38000028 | PubTator, text mining | PubMed |
| CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma. | J Exp Clin Cancer Res | 2023 | 37993874 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2317/papers?page=10